Navigation Links
Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics (TCT) Meeting
Date:9/23/2009

IRVINE, Calif., Sept. 23 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), a market leader in laser transmyocardial revascularization (TMR), today announced that it sponsored an educational symposium yesterday in conjunction with the 21st Annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in San Francisco.

The symposium, titled "Opportunities in Refractory Angina" was attended by over 80 cardiologists. The Program Chairman was Christopher J. White MD, Chairman, Department of Cardiovascular Disease Ochsner Clinic, and the faculty included Timothy D. Henry MD Director of Research Minneapolis Heart Institute, Marvin J. Slepian MD, Clinical Professor of Medicine University of Arizona and Michael J. Bates, Cardiothoracic Surgeon Ochsner Clinic.

"The challenge of effectively treating patients with refractory angina is that these patients may be followed by any one of thousands of cardiologists, internists, general practitioners, and at times heart failure specialists. The TCT program was designed to update the cardiology community on clinical options and in the case of Dr. Henry's presentation, effective strategies for cardiologists to build a refractory angina practice" stated Paul J. McCormick Executive Chairman Cardiogenesis. He continued "we believe we have a solid opportunity for our current technology by working with the cardiology community to develop patient referrals. Considering the early clinical results achieved, we believe that opportunity can significantly increase with the addition of various biologics. We have a meeting scheduled with the FDA on October 21 in Rockville, MD to discuss our IDE submission for our PHOENIX(R) Combination Delivery System."

About Cardiogenesis Corporation

Cardiogenesis is a medical device company specializing in the therapies for the treatment of chronic cardiac ischemia. The
'/>"/>

SOURCE Cardiogenesis Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cardiogenesis Receives FDA Approval for PEARL 5.0 Robotic Hand Piece
2. Cardiogenesis Corporation to Report 2007 Fourth Quarter and Year-End Results on March 4th
3. Cardiogenesis Corporation Reports Delay in Earnings Release and Conference Call
4. Cardiogenesis Corporation Announces Rescheduled Fourth Quarter and Full Year 2007 Earnings Release
5. Cardiogenesis Corporation to Report 2008 First Quarter Results on May 15th
6. Cardiogenesis Reports First Quarter 2008 Results
7. Cardiogenesis Announces Preliminary Results Combining TMR + Platelet Rich Plasma (PRP)
8. Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C.
9. Cardiogenesis Corporation to Report Third Quarter 2008 Results on November 13th
10. Cardiogenesis Announces Successful Educational Symposium at Society of Thoracic Surgeons Meeting in San Francisco
11. Cardiogenesis Corporation to Report 2008 Fourth Quarter and Year-End Results on March 31st
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) ... but some of the changes brought about by the ... New research has found that people with diabetes ... higher risk of having a severe low blood sugar ... to people with diabetes who aren,t depressed. ...
(Date:5/21/2013)... charged gold nanoparticles are usually toxic to cells, ... toxicity. Mayo Clinic researchers found out why, and ... ovarian cancer cells. The discovery is detailed in ... of Biological Chemistry ., "This study identifies a ... preventing the cell death or apoptosis which should ...
(Date:5/21/2013)... The team at Comfort &Harmony™, a leader in nurturing baby ... nursing pillow. , Nursing pillows are designed for ... , In a nursing pillow, important things to look ... at Comfort & Harmony, kept this list in mind when ... needs to fit a mom’s body and feel comfortable. Some ...
(Date:5/21/2013)... May 21, 2013 Vyopta Incorporated, ... automation applications for video collaboration, today announced the ... index evaluates key performance metrics related to quality, ... immediate, aggregated indicator of the performance of their ... Vyopta vAnalytics™ application, the vRating™ delivers high level ...
(Date:5/21/2013)... Ohio universities and four hospitals have joined with the ... research program aimed exclusively at finding the unknown causes ... invest $10 million in the program over five years. ... -- Ohio Collaborative is a unique research enterprise," says ... Dimes. "This new transdisciplinary, team-based research model will leverage ...
Breaking Medicine News(10 mins):Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2Health News:Comfort and Harmony™ Shares Tips on What to Look for in a Nursing Pillow 2Health News:Comfort and Harmony™ Shares Tips on What to Look for in a Nursing Pillow 3Health News:New vRating™ Video and Unified Communications Scoring System Delivers Innovative Approach to Measure Performance and ROI for Collaboration Networks 2Health News:New vRating™ Video and Unified Communications Scoring System Delivers Innovative Approach to Measure Performance and ROI for Collaboration Networks 3Health News:New multi-million dollar research center aims to solve the mystery of premature birth 2Health News:New multi-million dollar research center aims to solve the mystery of premature birth 3
... getting the medications they need, researchers say , , MONDAY, ... American children have attention-deficit/hyperactivity disorder (ADHD), but only 32 ... , That,s the sobering conclusion of a landmark new ... doctors consider the "gold standard" of diagnostic criteria -- ...
... Stock in the SDAX as Per September 6, 2007 ... Outside the Normal Schedule, ... September, DÜSSELDORF, Germany, September 3 Gerresheimer AG has,been listed in ... one of the largest IPOs of the year, with a total,issue volume ...
... Belgium, September 3 KFH has announced that ... ISO 13485 and ISO,9001:2000 quality management systems with ... Dr Sally Sennitt, MD, says: "We are delighted,to ... systems,through working with BSI. It is a major ...
... year-round consumption of fresh leafy greens such as lettuce ... produce free from contamination by food poisoning bacteria, according ... at the Society for General Microbiologys 161st Meeting at ... September 2007. , The only land suitable for supplying ...
... treatment of schizophrenia, INDIANAPOLIS, Sept. 2 An ... Medicine,demonstrates that for the first time in humans a ... mGlu2/3 has antipsychotic activity. The study,was sponsored by Eli ... this study - a randomized, double-blind, placebo-controlled clinical,trial - ...
... buzzing with electrical activity created by sodium and potassium ... pores. To prevent the constant chatter from descending into ... be tightly regulated. , One possibility is to ... dumpster, discovered researchers at the Salk Institute for Biological ...
Cached Medicine News:Health News:9% of U.S. Kids Have ADHD 2Health News:9% of U.S. Kids Have ADHD 3Health News:Lettuce, leafy greens and E. coli 2Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 2Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 3Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 4Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 5Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 6Health News:A drug-sensitive 'traffic cop' tells potassium channels to get lost 2
(Date:5/21/2013)... , May 21, 2013 STAAR Surgical Company ... and marketer of minimally invasive ophthalmic products, today announced ... to review the Company,s recent financial results and business ... Surgical will present at the 38 th Annual ... at the Westin Waterfront Hotel on Wednesday, ...
(Date:5/20/2013)... 2013  Volcano Corporation (NASDAQ: VOLC ) ... tools designed to enhance the diagnosis and treatment of ... highlight its efforts to expand research and innovation surrounding ... and iFR ® (Instant Wave-Free Ratio™) 1 ... at EuroPCR 2013 in Paris . ...
(Date:5/20/2013)... May 20, 2013 The Board of ... companies include OMNIlife science®, Inc., Enztec, Ltd., and Praxim, ... Board.  Guy Mayer , an ... of the Board of Directors and David Johnson, an ... director. Before joining OSI as Board ...
Breaking Medicine Technology:STAAR Surgical To Present At Upcoming Investor Conferences 2Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 2Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 3Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 4Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 3
... 2011 Caliper Life Sciences, Inc. (NASDAQ: ... for life science companies, today announced that Kevin Hrusovsky, President ... BioConference Live event, which was held on October 26, and ... Forum on October 27 held at Harvard Medical School. ...
... Conn., Nov. 7, 2011 Boehringer Ingelheim Pharmaceuticals, Inc. ... a Phase 2b study, SOUND-C2, that showed the combination ... compounds – the protease inhibitor BI 201335 and the ... successful in reducing viral load below the lower limit ...
Cached Medicine Technology:Caliper CEO Kevin Hrusovsky Presented Vision for Revolutionizing Medicine 2Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 2Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 3Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 4Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 5
... Room Knee Brace frees the ... the time-consuming post-op fitting and ... more complex brace designs. The ... provides the same benefits as ...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
SofTec Genu is the first functional brace that provides full soft tissue control, enhances natural muscle movement, prevents atrophy, increases proprioception and controls A/P laxity....
Medicine Products: